Lack of association of the CD14 promoter polymorphism −159C/T with Caucasian inflammatory bowel disease

References

• Binder V. Genetic epidemiology in inflammatory bowel disease. Dig Dis 1998;16:351–5.
   PubMed Web of Science ®Google Scholar
• Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84–8.
   PubMed Web of Science ®Google Scholar
• Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, et al. Familial aggregation in Crohn’s disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597–603.
   PubMed Web of Science ®Google Scholar
• Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990–6.
   Google Scholar
• Cavanaugh J, IBDIGC. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 2001;68:1165–71.
   PubMed Web of Science ®Google Scholar
• Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999;65: 1647–55.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:1212–7.
   PubMed Web of Science ®Google Scholar
• Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, et al. Linkage of Crohn’s disease to the major histocompatibility complex region is detected by multiple non-parametric analyses. Gut 1999;44:519–26.
   Google Scholar
• Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001;29:223–8.
   PubMed Web of Science ®Google Scholar
• Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 2001;357:1925–8.
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603.
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411: 603–6.
   PubMed Web of Science ®Google Scholar
• Cavanaugh JA, Callen DF, Wilson SR, Stanford PM, Sraml ME, Gorska M, et al. Analysis of Australian Crohn’s disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann Hum Genet 1998;62:291–8.
   PubMed Web of Science ®Google Scholar
• Cavanaugh JA, Adams KE, Quak EJ, Bryce ME, O’Callaghan NJ, Rodgers HJ, et al. CARD15/NOD2 risk alleles in the development of Crohn’s disease in the Australian population. Ann Hum Genet 2003;67: 35–41.
   Google Scholar
• van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-kappaB transcription factors. Hum Mol Genet 2002;11:1281–9.
   PubMed Web of Science ®Google Scholar
• O’Callaghan NJ, Adams KE, van Heel DA, Cavanaugh JA. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population. Scand J Gastroenterol 2003;38: 533–4.
   Google Scholar
• Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, et al. A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002;37:189–91.
   PubMed Web of Science ®Google Scholar
• Obana N, Takahashi S, Kinouchi Y, Negoro K, Takagi S, Hiwatashi N, et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand J Gastroenterol 2002;37:699–704.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Zaitsu M, Hara M, Yokota G, Watanabe M, Ueda Y, et al. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 2003;143:357–62.
   PubMed Web of Science ®Google Scholar
• Buckova D, Holla LI, Schuller M, Znojil V, Vacha J. Two CD14 promoter polymorphisms and atopic phenotypes in Czech patients with IgE-mediated allergy. Allergy 2003;58: 1023–6.
   Google Scholar
• Koppelman GH, Reijmerink NE, Colin SO, Howard TD, Whittaker PA, Meyers DA, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001;163:965–9.
   PubMed Web of Science ®Google Scholar
• Leung TF, Tang NL, Sung YM, Li AM, Wong GW, Chan IH, et al. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol 2003;14:255–60.
   PubMed Web of Science ®Google Scholar
• Klein W, Tromm A, Griga T, Folwaczny C, Hocke M, Eitner K, et al. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease. Scand J Gastroenterol 2003;38:834–6.
   PubMed Web of Science ®Google Scholar
• Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998;392:505–9.
   PubMed Web of Science ®Google Scholar
• Maliszewski CR. CD14 and immune response to lipopolysaccharide. Science 1991;252:1321–2.
   PubMed Web of Science ®Google Scholar
• Peters KE, Cavanaugh JA. CARD15 and Crohn’s disease. Journal of Gastroenterology and Hepatology 2004;19:830.
   PubMed Web of Science ®Google Scholar
• Mirza MM, Fisher SA, King K, Cuthbert AP, Hampe J, Sanderson J, et al. Genetic Evidence for Interaction of the 5q31 Cytokine Locus and the CARD15 Gene in Crohn Disease. Am J Hum Genet 2003;72:1018–22.
   PubMed Web of Science ®Google Scholar
• Giallourakis C, Stoll M, Miller K, Hampe J, Lander ES, Daly MJ, et al. IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 2003;73:205–11.
   PubMed Web of Science ®Google Scholar
• Nimmo ER, Arnott IDR, Drummond HE, Mackinlay E, Moorecroft J, Fennel J, et al. Mutations of toll-like receptor 4 and CD14 genes are not associated with susceptibility or disease behaviour in inflammatory bowel disease. Gastroenterology; 2003;124:A–373.
   Google Scholar
• Philipose Z, Mendall MA, Poullis A, Ang L. Risk of Crohn’s disease associated with smoking may be influenced by CD14–159C/T promoter region gene polymorphism. Gut 2003;52:A209.
   Google Scholar
• Sugimura M, Kinouchi Y, Takahashi S, Aihara H, Takagi S, Negoro K, et al. CARD15/NOD2 mutational analysis in Japanese patients with Crohn’s disease. Clin Genet 2003; 63:160–2.
   PubMed Web of Science ®Google Scholar
• Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004;35:471–5.
   Google Scholar